1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ELK7082
Human CA19-5(Carbohydrate Antigen 19-5) ELISA Kit
Human CA19-5(Carbohydrate Antigen 19-5) ELISA Kit
Human CA19-5(Carbohydrate Antigen 19-5) ELISA Kit
Overview
| Product name: | Human CA19-5(Carbohydrate Antigen 19-5) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | CA19-5 |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 0.86 ng/mL |
| Standard: | 200 ng/mL |
| Range: | 3.13-200 ng/mL |
| Sample Type: | Serum, plasma and other biological fluids. |
| Assay Length: | 2h |
| Research Area: | Tumor immunity;Hepatology;Gastroenterology; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human CA19-5 protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human CA19-5. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human CA19-5 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 200.00 | 0.191 | — |
| 100.00 | 0.367 | — |
| 50.00 | 0.621 | — |
| 25.00 | 0.833 | — |
| 12.50 | 1.139 | — |
| 6.25 | 1.578 | — |
| 3.13 | 1.799 | — |
| 0.00 | 2.101 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant CA19-5 and the recovery rates were calculated by comparing the measured value to the expected amount of CA19-5 in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 82-94% | 88% |
| EDTA plasma(n=5) | 97-107% | 102% |
| Heparin plasma(n=5) | 87-99% | 95% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of CA19-5 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 90-99% | 97-106% | 87-98% | 85-92% |
| EDTA plasma(n=5) | 88-97% | 90-99% | 87-103% | 82-97% |
| Heparin plasma(n=5) | 91-99% | 86-92% | 91-99% | 95-102% |
Share
